| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 7, 1256-1265, Copyright © 1993 by Endocrine Society
ARTICLES |
L Tung, MK Mohamed, JP Hoeffler, GS Takimoto and KB Horwitz
Department of Medicine, University of Colorado Health Sciences Center Denver 80262.
When antagonist-occupied steroid receptors have agonist-like effects, the clinical consequences are grave. We present evidence that human progesterone B-receptors (hPRB) when occupied by progesterone antagonists, inappropriately activate transcription by an unusual mechanism that does not require the canonical progesterone response element (PRE). In HeLa cells cotransfected with a PRE-tk- chloramphenicol acetyltransferase reporter and a hPRB expression vector, strong transcription is seen not only when receptors are activated by the agonist R5020, but also in the presence of the three antiprogestins, RU486, ZK112993, and ZK98299. Human PRB occupied by ZK98299 do not bind to a PRE, suggesting that the transcriptional stimulation is independent of DNA binding. Indeed, a tk-chloramphenicol acetyltransferase promoter-reporter lacking the PRE loses transcriptional activation by the agonist, but retains transactivation by the three antagonists. The PRE-independent antagonist-induced transcription requires that hPRB have an intact DNA-binding domain, but hPR target gene specificity is not required, because a hPRB mutant that binds an estrogen response element still activates transcription. It appears that antagonist-occupied hPR activate transcription without binding to a PRE, perhaps by interacting with tethering proteins instead. Even a gene that is not a normal progesterone target could be aberrantly activated. Human cells contain equimolar amounts of hPRB and the N-terminally truncated natural isotype, hPRA. Unlike hPRB, hPRA are not transcriptionally activated by progesterone antagonists. We, therefore, tested the effects of antagonists when the two receptor isotypes are coexpressed and found that A-receptors can annul the inappropriate transcription by B-receptors. Thus, when both receptor forms are present, the hPRA phenotype is dominant. Moreover, pure hPRB/hPRA heterodimers, produced by fos/jun leucine zipper domain-hPR chimeras, also have the inactive transcriptional phenotype of hPRA. Our studies suggest not only that the two hPR isotypes are functionally quite different, but also that some of the agonist-like transcriptional effects of antagonist-occupied B-receptors proceed through novel mechanisms.
This article has been cited by other articles:
![]() |
D. J. Rickard, U. T. Iwaniec, G. Evans, T. E. Hefferan, J. C. Hunter, K. M. Waters, J. P. Lydon, B. W. O'Malley, S. Khosla, T. C. Spelsberg, et al. Bone Growth and Turnover in Progesterone Receptor Knockout Mice Endocrinology, May 1, 2008; 149(5): 2383 - 2390. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Xu, N. Ohara, J. Liu, M. Amano, R. Sitruk-Ware, S. Yoshida, and T. Maruo Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells Mol. Hum. Reprod., March 1, 2008; 14(3): 181 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ohta, T. Maruyama, H. Uchida, M. Ono, T. Nagashima, T. Arase, T. Kajitani, H. Oda, M. Morita, and Y. Yoshimura Glycodelin blocks progression to S phase and inhibits cell growth: a possible progesterone-induced regulator for endometrial epithelial cell growth Mol. Hum. Reprod., January 1, 2008; 14(1): 17 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Carnevale, C. J. Proietti, M. Salatino, A. Urtreger, G. Peluffo, D. P. Edwards, V. Boonyaratanakornkit, E. H. Charreau, E. B. de Kier Joffe, R. Schillaci, et al. Progestin Effects on Breast Cancer Cell Proliferation, Proteases Activation, and in Vivo Development of Metastatic Phenotype All Depend on Progesterone Receptor Capacity to Activate Cytoplasmic Signaling Pathways Mol. Endocrinol., June 1, 2007; 21(6): 1335 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Merlino, T. N. Welsh, H. Tan, L. J. Yi, V. Cannon, B. M. Mercer, and S. Mesiano Nuclear Progesterone Receptors in the Human Pregnancy Myometrium: Evidence that Parturition Involves Functional Progesterone Withdrawal Mediated by Increased Expression of Progesterone Receptor-A J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1927 - 1933. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Madauss, E. T. Grygielko, S.-J. Deng, A. C. Sulpizio, T. B. Stanley, C. Wu, S. A. Short, S. K. Thompson, E. L. Stewart, N. J. Laping, et al. A Structural and in Vitro Characterization of Asoprisnil: A Selective Progesterone Receptor Modulator Mol. Endocrinol., May 1, 2007; 21(5): 1066 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Madsen, D. A. MacIntyre, S. Mesiano, and R. Smith Progesterone Receptor or Cytoskeletal Protein? Reproductive Sciences, April 1, 2007; 14(3): 217 - 222. [Abstract] [PDF] |
||||
![]() |
A. Shatnawi, T. Tran, and M. Ratnam R5020 and RU486 Act as Progesterone Receptor Agonists to Enhance Sp1/Sp4-Dependent Gene Transcription by an Indirect Mechanism Mol. Endocrinol., March 1, 2007; 21(3): 635 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sasaki, N. Ohara, Q. Xu, J. Wang, D. A. DeManno, K. Chwalisz, S. Yoshida, and T. Maruo A Novel Selective Progesterone Receptor Modulator Asoprisnil Activates Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Mediated Signaling Pathway in Cultured Human Uterine Leiomyoma Cells in the Absence of Comparable Effects on Myometrial Cells J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 616 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Faivre and C. A. Lange Progesterone Receptors Upregulate Wnt-1 To Induce Epidermal Growth Factor Receptor Transactivation and c-Src-Dependent Sustained Activation of Erk1/2 Mitogen-Activated Protein Kinase in Breast Cancer Cells Mol. Cell. Biol., January 15, 2007; 27(2): 466 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pilka, I. Oborna, V. Lichnovsky, P. Havelka, H. Fingerova, P. Eriksson, S. Hansson, and B. Casslen Endometrial expression of the estrogen-sensitive genes MMP-26 and TIMP-4 is altered by a substitution protocol without down-regulation in IVF patients Hum. Reprod., December 1, 2006; 21(12): 3146 - 3156. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Man, H.-Y. Li, P.-J. Zhang, T. Zhou, K. He, X. Pan, B. Liang, A.-L. Li, J. Zhao, W.-L. Gong, et al. PIAS3 induction of PRB sumoylation represses PRB transactivation by destabilizing its retention in the nucleus Nucleic Acids Res., November 14, 2006; 34(19): 5552 - 5566. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. O'Brien, T. J. Peterson, M. H. Tong, E.-J. Lee, L. E. Pfaff, S. C. Hewitt, K. S. Korach, J. Weiss, and J. L. Jameson Estrogen-induced Proliferation of Uterine Epithelial Cells Is Independent of Estrogen Receptor {alpha} Binding to Classical Estrogen Response Elements J. Biol. Chem., September 8, 2006; 281(36): 26683 - 26692. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shao, E. Egecioglu, B. Weijdegard, K. Ljungstrom, C. Ling, J. Fernandez-Rodriguez, and H. Billig Developmental and hormonal regulation of progesterone receptor A-form expression in female mouse lung in vivo: interaction with glucocorticoid receptors. J. Endocrinol., September 1, 2006; 190(3): 857 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Xu, N. Ohara, W. Chen, J. Liu, H. Sasaki, A. Morikawa, R. Sitruk-Ware, E. D.B. Johansson, and T. Maruo Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells Hum. Reprod., September 1, 2006; 21(9): 2408 - 2416. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Mani, A. M. Reyna, J. Z. Chen, B. Mulac-Jericevic, and O. M. Conneely Differential Response of Progesterone Receptor Isoforms in Hormone-Dependent and -Independent Facilitation of Female Sexual Receptivity Mol. Endocrinol., June 1, 2006; 20(6): 1322 - 1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. N. Jabbour, R. W. Kelly, H. M. Fraser, and H. O. D. Critchley Endocrine Regulation of Menstruation Endocr. Rev., February 1, 2006; 27(1): 17 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Graham, M. L. Yager, H. D. Hill, K. Byth, G. M. O'Neill, and C. L. Clarke Altered Progesterone Receptor Isoform Expression Remodels Progestin Responsiveness of Breast Cancer Cells Mol. Endocrinol., November 1, 2005; 19(11): 2713 - 2735. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chabbert-Buffet, G. Meduri, P. Bouchard, and I. M. Spitz Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications Hum. Reprod. Update, May 1, 2005; 11(3): 293 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mesiano Myometrial Progesterone responsiveness and the Control of Human Parturition Reproductive Sciences, May 1, 2004; 11(4): 193 - 202. [Abstract] [PDF] |
||||
![]() |
J. Wu, J. Richer, K. B. Horwitz, and S. M. Hyder Progestin-Dependent Induction of Vascular Endothelial Growth Factor in Human Breast Cancer Cells: Preferential Regulation by Progesterone Receptor B Cancer Res., March 15, 2004; 64(6): 2238 - 2244. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Arnett-Mansfield, A. deFazio, P. A. Mote, and C. L. Clarke Subnuclear Distribution of Progesterone Receptors A and B in Normal and Malignant Endometrium J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1429 - 1442. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Sereepapong, P. Chotnopparatpattara, S. Taneepanichskul, R. Markham, P. Russell, and I. S. Fraser Endometrial progesterone and estrogen receptors and bleeding disturbances in depot medroxyprogesterone acetate users Hum. Reprod., March 1, 2004; 19(3): 547 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Smith and B. W. O'Malley Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators Endocr. Rev., February 1, 2004; 25(1): 45 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. C. L. Lin, C. T. Woon, S. E. Aw, and C. Guo Distinct Molecular Pathways Mediate Progesterone-Induced Growth Inhibition And Focal Adhesion Endocrinology, December 1, 2003; 144(12): 5650 - 5657. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Molenda, C. P. Kilts, R. L. Allen, and M. J. Tetel Nuclear Receptor Coactivator Function in Reproductive Physiology and Behavior Biol Reprod, November 1, 2003; 69(5): 1449 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-L. Zhang, D. Zhang, F. J. Michel, J. L. Blum, F. A. Simmen, and R. C. M. Simmen Selective Interactions of Kruppel-like Factor 9/Basic Transcription Element-binding Protein with Progesterone Receptor Isoforms A and B Determine Transcriptional Activity of Progesterone-responsive Genes in Endometrial Epithelial Cells J. Biol. Chem., June 6, 2003; 278(24): 21474 - 21482. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shao, E. Markstrom, P. A. Friberg, M. Johansson, and H. Billig Expression of Progesterone Receptor (PR) A and B Isoforms in Mouse Granulosa Cells: Stage-Dependent PR-Mediated Regulation of Apoptosis and Cell Proliferation Biol Reprod, March 1, 2003; 68(3): 914 - 921. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Leonhardt and D. P. Edwards Mechanism of Action of Progesterone Antagonists Experimental Biology and Medicine, December 1, 2002; 227(11): 969 - 980. [Abstract] [Full Text] |
||||
![]() |
X. Fang, S. Wong, and B. F. Mitchell Messenger RNA for progesterone receptor isoforms in the late-gestation rat uterus Am J Physiol Endocrinol Metab, December 1, 2002; 283(6): E1167 - E1172. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Abdel-Hafiz, G. S. Takimoto, L. Tung, and K. B. Horwitz The Inhibitory Function in Human Progesterone Receptor N Termini Binds SUMO-1 Protein to Regulate Autoinhibition and Transrepression J. Biol. Chem., September 6, 2002; 277(37): 33950 - 33956. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Jacobsen, J. K. Richer, S. A. Schittone, and K. B. Horwitz New Human Breast Cancer Cells to Study Progesterone Receptor Isoform Ratio Effects and Ligand-independent Gene Regulation J. Biol. Chem., July 26, 2002; 277(31): 27793 - 27800. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mesiano, E.-C. Chan, J. T. Fitter, K. Kwek, G. Yeo, and R. Smith Progesterone Withdrawal and Estrogen Activation in Human Parturition Are Coordinated by Progesterone Receptor A Expression in the Myometrium J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2924 - 2930. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Richer, B. M. Jacobsen, N. G. Manning, M. G. Abel, D. M. Wolf, and K. B. Horwitz Differential Gene Regulation by the Two Progesterone Receptor Isoforms in Human Breast Cancer Cells J. Biol. Chem., February 8, 2002; 277(7): 5209 - 5218. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Christian, Y. Pohnke, R. Kempf, B. Gellersen, and J. J. Brosens Functional Association of PR and CCAAT/Enhancer-Binding Protein {beta} Isoforms: Promoter-Dependent Cooperation between PR-B and Liver-Enriched Inhibitory Protein, or Liver-Enriched Activatory Protein and PR-A in Human Endometrial Stromal Cells Mol. Endocrinol., January 1, 2002; 16(1): 141 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tung, T. Shen, M. G. Abel, R. L. Powell, G. S. Takimoto, C. A. Sartorius, and K. B. Horwitz Mapping the Unique Activation Function 3 in the Progesterone B-receptor Upstream Segment. TWO LXXLL MOTIFS AND A TRYPTOPHAN RESIDUE ARE REQUIRED FOR ACTIVITY J. Biol. Chem., October 19, 2001; 276(43): 39843 - 39851. [Abstract] [Full Text] [PDF] |
||||
![]() |
P A Mote, J F Johnston, T Manninen, P Tuohimaa, and C L Clarke Detection of progesterone receptor forms A and B by immunohistochemical analysis J. Clin. Pathol., August 1, 2001; 54(8): 624 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Arnett-Mansfield, A. deFazio, G. V. Wain, R. C. Jaworski, K. Byth, P. A. Mote, and C. L. Clarke Relative Expression of Progesterone Receptors A and B in Endometrioid Cancers of the Endometrium Cancer Res., June 1, 2001; 61(11): 4576 - 4582. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Giannoukos, D. Szapary, C. L. Smith, J. E. W. Meeker, and S. S. Simons Jr. New Antiprogestins with Partial Agonist Activity: Potential Selective Progesterone Receptor Modulators (SPRMs) and Probes for Receptor- and Coregulator-Induced Changes in Progesterone Receptor Induction Properties Mol. Endocrinol., February 1, 2001; 15(2): 255 - 270. [Abstract] [Full Text] |
||||
![]() |
J. Gao, J. Mazella, M. Tang, and L. Tseng Ligand-Activated Progesterone Receptor Isoform hPR-A Is a Stronger Transactivator Than hPR-B for the Expression of IGFBP-1 (Insulin-Like Growth Factor Binding Protein-1) in Human Endometrial Stromal Cells Mol. Endocrinol., December 1, 2000; 14(12): 1954 - 1961. [Abstract] [Full Text] |
||||
![]() |
R. Runic, F. Schatz, L. Wan, R. Demopoulos, G. Krikun, and C. J. Lockwood Effects of Norplant on Endometrial Tissue Factor Expression and Blood Vessel Structure J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3853 - 3859. [Abstract] [Full Text] |
||||
![]() |
G. R. ATTIA, K. ZEITOUN, D. EDWARDS, A. JOHNS, B. R. CARR, and S. E. BULUN Progesterone Receptor Isoform A But Not B Is Expressed in Endometriosis J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2897 - 2902. [Abstract] [Full Text] |
||||
![]() |
L. N. Petz and A. M. Nardulli Sp1 Binding Sites and An Estrogen Response Element Half-Site Are Involved in Regulation of the Human Progesterone Receptor A Promoter Mol. Endocrinol., July 1, 2000; 14(7): 972 - 985. [Abstract] [Full Text] |
||||
![]() |
P. H. Giangrande, E. A. Kimbrel, D. P. Edwards, and D. P. McDonnell The Opposing Transcriptional Activities of the Two Isoforms of the Human Progesterone Receptor Are Due to Differential Cofactor Binding Mol. Cell. Biol., May 1, 2000; 20(9): 3102 - 3115. [Abstract] [Full Text] |
||||
![]() |
U. Ottander, K. Hosokawa, K. Liu, A. Bergh, T. Ny, and J. I. Olofsson A Putative Stimulatory Role of Progesterone Acting via Progesterone Receptors in the Steroidogenic Cells of the Human Corpus Luteum Biol Reprod, March 1, 2000; 62(3): 655 - 663. [Abstract] [Full Text] |
||||
![]() |
D. L. Clemm, L. Sherman, V. Boonyaratanakornkit, W. T. Schrader, N. L. Weigel, and D. P. Edwards Differential Hormone-Dependent Phosphorylation of Progesterone Receptor A and B Forms Revealed by a Phosphoserine Site-Specific Monoclonal Antibody Mol. Endocrinol., January 1, 2000; 14(1): 52 - 65. [Abstract] [Full Text] |
||||
![]() |
B. S. Katzenellenbogen Mechanisms of Action and Cross-Talk Between Estrogen Receptor and Progesterone Receptor Pathways Reproductive Sciences, January 1, 2000; 7(1_suppl): S33 - S37. [Abstract] [PDF] |
||||
![]() |
J. Tan, B. C. Paria, S. K. Dey, and S. K. Das Differential Uterine Expression of Estrogen and Progesterone Receptors Correlates with Uterine Preparation for Implantation and Decidualization in the Mouse Endocrinology, November 1, 1999; 140(11): 5310 - 5321. [Abstract] [Full Text] |
||||
![]() |
E. M. McGowan and C. L. Clarke Effect of Overexpression of Progesterone Receptor A on Endogenous Progestin-Sensitive Endpoints in Breast Cancer Cells Mol. Endocrinol., October 1, 1999; 13(10): 1657 - 1671. [Abstract] [Full Text] |
||||
![]() |
J. J. Brosens, N. Hayashi, and J. O. White Progesterone Receptor Regulates Decidual Prolactin Expression in Differentiating Human Endometrial Stromal Cells Endocrinology, October 1, 1999; 140(10): 4809 - 4820. [Abstract] [Full Text] |
||||
![]() |
V. Boonyaratanakornkit, D. D. Strong, S. Mohan, D. J. Baylink, C. A. Beck, and T. A. Linkhart Progesterone Stimulation of Human Insulin-like Growth Factor-binding Protein-5 Gene Transcription in Human Osteoblasts Is Mediated by a CACCC Sequence in the Proximal Promoter J. Biol. Chem., September 10, 1999; 274(37): 26431 - 26438. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Mote, R. L. Balleine, E. M. McGowan, and C. L. Clarke Colocalization of Progesterone Receptors A and B by Dual Immunofluorescent Histochemistry in Human Endometrium during the Menstrual Cycle J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2963 - 2971. [Abstract] [Full Text] |
||||
![]() |
M. J. Tetel, P. H. Giangrande, S. A. Leonhardt, D. P. McDonnell, and D. P. Edwards Hormone-Dependent Interaction between the Amino- and Carboxyl-Terminal Domains of Progesterone Receptor in Vitro and in Vivo Mol. Endocrinol., June 1, 1999; 13(6): 910 - 924. [Abstract] [Full Text] |
||||
![]() |
Y. G. Shanker and A. Jagannadha Rao Progesterone receptor expression in the human placenta Mol. Hum. Reprod., May 1, 1999; 5(5): 481 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Vaßen, W. Wegrzyn, and L. Klein-Hitpass Human Insulin Receptor Substrate-2 (IRS-2) Is a Primary Progesterone Response Gene Mol. Endocrinol., March 1, 1999; 13(3): 485 - 494. [Abstract] [Full Text] |
||||
![]() |
D. A. Schreihofer, E. M. Resnick, A. Y. Soh, and M. A. Shupnik Transcriptional Regulation by a Naturally Occurring Truncated Rat Estrogen Receptor (ER), Truncated ER Product-1 (TERP-1) Mol. Endocrinol., February 1, 1999; 13(2): 320 - 329. [Abstract] [Full Text] |
||||
![]() |
V. P. Fomin, B. E. Cox, and R. A. Word Effect of progesterone on intracellular Ca2+ homeostasis in human myometrial smooth muscle cells Am J Physiol Cell Physiol, February 1, 1999; 276(2): C379 - C385. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Lockwood, G. Krikun, V. A. Hausknecht, C. Papp, and F. Schatz Matrix Metalloproteinase and Matrix Metalloproteinase Inhibitor Expression in Endometrial Stromal Cells during Progestin-Initiated Decidualization and Menstruation-Related Progestin Withdrawal Endocrinology, November 1, 1998; 139(11): 4607 - 4613. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Huse, S. B. Verca, P. Matthey, and S. Rusconi Definition of a Negative Modulation Domain in the Human Progesterone Receptor Mol. Endocrinol., September 1, 1998; 12(9): 1334 - 1342. [Abstract] [Full Text] |
||||
![]() |
J. W. Clemens, R. L. Robker, W. L. Kraus, B. S. Katzenellenbogen, and J. S. Richards Hormone Induction of Progesterone Receptor (PR) Messenger Ribonucleic Acid and Activation of PR Promoter Regions in Ovarian Granulosa Cells: Evidence for a Role of Cyclic Adenosine 3',5'-Monophosphate but Not Estradiol Mol. Endocrinol., August 1, 1998; 12(8): 1201 - 1214. [Abstract] [Full Text] |
||||
![]() |